Prelude Therapeutics Inc SEC filings PRLD
Prelude Therapeutics Inc has 389 filings in SEC EDGAR's recent list, going back to Jul 11, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Apr 21, 2026 | — |
| 424B5 | Prospectus supplement | Mar 12, 2026 | — |
| S-8 | Employee stock plan registration | Mar 10, 2026 | — |
| S-3 | Shelf registration | Dec 10, 2025 | — |
| S-8 | Employee stock plan registration | Mar 10, 2025 | — |
| S-3 | Shelf registration | May 30, 2024 | — |
| S-3/A | Filing | May 6, 2024 | — |
| S-3 | Shelf registration | Feb 16, 2024 | — |
| S-8 | Employee stock plan registration | Feb 16, 2024 | — |
| 424B5 | Prospectus supplement | May 19, 2023 | — |
| FWP | Free writing prospectus | May 18, 2023 | — |
| 424B5 | Prospectus supplement | May 17, 2023 | — |
| 424B5 | Prospectus supplement | Mar 15, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| S-3 | Shelf registration | Nov 12, 2021 | — |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| 424B4 | Prospectus | Jan 7, 2021 | — |
| S-1MEF | Filing | Jan 6, 2021 | — |
| S-1 | Registration statement | Jan 4, 2021 | — |
| 424B4 | Prospectus | Sep 25, 2020 | — |
| S-8 | Employee stock plan registration | Sep 25, 2020 | — |
| S-1/A | Amended registration statement | Sep 21, 2020 | — |
| S-1/A | Amended registration statement | Sep 16, 2020 | — |
| S-1 | Registration statement | Sep 4, 2020 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRLD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1678660
- Former names
- Prelude Therapeutics Inc. (until Oct 20, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.